ReviewHypertension research : official journal of the Japanese Society of Hypertension2026
Telemonitoring in the era of digital hypertension: beyond remote blood pressure monitoring.
Review in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Telemonitoring, typically incorporating home blood pressure (BP) monitoring, has become an established component of hypertension management. Conventional telemonitoring has primarily relied on remote transmission of BP measurements to support clinician-directed treatment adjustment. However, recent advances in digital health technologies and the emergence of digital hypertension have substantially broadened the role of telemonitoring in hypertension care. Within the framework of digital hypertension, telemonitoring is evolving beyond simple BP surveillance in three major domains. First, advances in data monitoring enable the integration of multidimensional health information, including physical activity, sleep patterns, medication adherence, and environmental exposures, with longitudinal BP measurements. Second, physician-support technologies, such as automated data integration, clinical decision-support systems, and artificial intelligence-based analytics, facilitate the interpretation of large-scale patient-generated data and support timely clinical intervention. Third, patient-support technologies, including digital therapeutics, provide continuous behavioral interventions and self-management support between clinic visits. Despite these advances, several challenges remain, including ensuring data quality and standardization, integration into clinical workflows, long-term patient engagement, digital inequalities, and concerns regarding privacy and data governance. Future research should focus on optimizing the clinical use of multidimensional health data, evaluating the effects of advanced telemonitoring strategies on long-term clinical outcomes, and establishing effective implementation models for routine practice. In the era of digital hypertension, telemonitoring is evolving from a BP monitoring tool into a comprehensive platform for personalized, data-driven, and continuous hypertension management.
Indexed as
Identifiers
42823537What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.